Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. He is the former Senior Vice President, Chief Medical Officer and Chief Opportunity Officer of Illumina. He currently chairs the Grand Challenges in Cancer program of Cancer Research UK. Previously, he has served as the Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.